Clear Street Group (CLRS) cut the number of shares it's offering by more than half and lowered its expected price range by ~36% after investors pushed back on its previous IPO expectations that could ...

Holtec International, a nuclear energy company that’s on the verge of reopening a shuttered reactor in Michigan, has filed confidentially with the SEC to go public. It could be one of the biggest IPOs ...

The broadening out of the stock market rally is starting to show up in the initial public offering market, as well, with eight private companies making their Wall Street debuts this week—and only two ...

Bruce Kingsley used an Arduino project board to add sound, motion, and programmed lighting effects to this HO scale house. You can read his story and other Arduino ...

SpaceX is reportedly lining up four major Wall Street banks for a potential 2026 IPO — a move that could signal the long-awaited reopening of the public markets after a years-long IPO drought. In the ...

Crypto custody firm Copper is in early talks about a public listing, according to three people with knowledge of the matter. Goldman Sachs, Citi and Deutsche Bank are among the investment banks ...

EquipmentShare.com (EQPT) opened for trading with a 19% pop after the company priced its $747M IPO at $24.50 per share, which was the midpoint of the company's indicated range. At its peak, the stock ...

BitGo becomes first major crypto IPO of 2026, debuting on NYSE at a $2.1 billion valuation. Above-range pricing signals selective institutional appetite for regulated, custody-first crypto ...

One of the original and most important reasons Message Queuing Telemetry Transport (MQTT) became the de facto protocol for Internet of Things (IoT) is its ability to connect and control devices that ...

Strava has reportedly taken the first step toward becoming a public company by submitting a confidential IPO filing, with a potential stock market debut expected as early as spring 2026 Following a ...

Aktis Oncology exceeded its own expectations for its IPO in a good omen for those hoping for a more inviting public market this year. The company, which has accrued an impressive list of Big Pharma ...